MRFR

  Topiramate is an anticonvulsant medication primarily used to treat epilepsy and prevent migraines. In recent years, the  topiramate market   has seen substantial growth, driven by an increasing prevalence of neurological disorders, expanding applications in weight management, and rising awareness about mental health. This article delves into the current state of the topiramate market, examining its growth, key trends, and future prospects. Market Growth The global topiramate market has experienced significant growth due to the rising incidence of epilepsy and migraines. According to the World Health Organization (WHO), epilepsy affects approximately 50 million people worldwide, making it one of the most common neurological disorders. The increasing prevalence of this condition has driven demand for effective treatment options like topiramate. Additionally, migraines affect around 1 billion people globally, further fueling the demand for preventive medications. Pharmaceu...